Sézary syndrome during anti-IL17 treatment

Dermatol Ther. 2020 Nov;33(6):e14321. doi: 10.1111/dth.14321. Epub 2020 Sep 28.

Authors

Giulio Cortonesi¹, Emanuele Trovato¹, Elisa Cinotti¹, Stefano Gentileschi², Bruno Frediani², Pietro Rubegni¹

Affiliations

¹ Dermatology Section, Department of Medical, Surgical, and Neurological Sciences, Santa Maria Alle Scotte Hospital, Siena, Italy.
² Reumatology Section, Department of Medical, Surgical, and Neurological Sciences, Santa Maria Alle Scotte Hospital, Siena, Italy.

PMID: 32949439
DOI: 10.1111/dth.14321

No abstract available

Publication types

Letter

MeSH terms

Humans
Sezary Syndrome* / drug therapy
Skin Neoplasms* / drug therapy